Catalyst Wire Dossier Catalyst Wire Dossier

Ceftazidime-Avibactam (CAZ-AVI)

ceftazidime-avibactam · Pfizer
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Ceftazidime-Avibactam (CAZ-AVI), covering 2024-09-19 to 2024-10-21. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of CAZ-AVI in the Treatment of Infections Due to Carbapenem-resistant G- Pathogens in Chinese Adults [Phase 4]

See pricing